dizziness; vertigo; pain in arm /sore arm; this is a spontaneous report received from a contactable reporter(s) (consumer or other non hcp) from the regulatory agency (ra). regulatory number: gb-mhra-webcovid-202202120808306150-e8yz2 (ra). other case identifier(s): gb-mhra-adr 26614566 (ra). a female patient received bnt162b2 (comirnaty), administration date 09feb2022 (batch/lot number: unknown) as dose 1, single for covid-19 immunisation. relevant medical history included: "covid-19", start date: 05dec2021 (unspecified if ongoing), notes: unsure when symptoms stopped. the patient was not enrolled in clinical trial. the patient's concomitant medications were not reported. the following information was reported: dizziness (medically significant) with onset 11feb2022, outcome "not recovered", described as "dizziness"; vertigo (medically significant) with onset 11feb2022, outcome "not recovered", described as "vertigo"; pain in extremity (medically significant) with onset 09feb2022, outcome "recovered" (11feb2022), described as "pain in arm /sore arm". the patient underwent the following laboratory tests and procedures: sars-cov-2 test: (06dec2021) yes - positive covid-19 test. clinical course: the patient experienced sore arm day 1-2. on evening of day 2 and continuing from day 3 patient experienced intense dizziness / vertigo. patient has not tested positive for covid-19 since having the vaccine. no follow-up attempts are possible; information about lot/batch number cannot be obtained. no further information is expected

test date: 20211206; test name: covid-19 virus test; result unstructured data: test result:yes - positive covid-19 test

na

na